drugset / Trial / NCT01902134

Oral Treatment for Orthopaedic Post-operative Pain With Dexketoprofen Trometamol and Tramadol Hydrochloride

NCT01902134

Phase 3 Completed 641 enrolled Menarini Group
RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to evaluate the analgesic efficacy of single and repeated doses of fixed combination of dexketoprofen trometamol (DKP) and tramadol hydrochloride (TRAM) in comparison to the single agents (and placebo for the single dose phase only) Approximately 600 male and female patients presenting moderate to severe pain after an elective primary hip arthroplasty are eligible to be randomised provided that they experience moderate to severe pain on the day after surgery.

Timeline

Start
2013-04
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexketoprofen Small molecule 25 mg Oral
Subject Tramadol Other / unclassified 75 mg Oral
Subject Tramadol Other / unclassified 100 mg Oral

Indications

No indication recorded.